What You Should Know:
- Qnovia (formerly Respira Technologies)—a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases—has raised $17M in Series A funding led by Blue Ledge Capital and included DG Ventures, Evolution VC Partners, Gaingels, TL Capital, and Vice Ventures.
- Qnovia will use the Series A proceeds to advance its NRT drug candidate through an IND submission with the FDA and begin human
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
XpertDox Secures $1.5M to Automate Medical Coding Process
What You Should Know:
- Today, XpertDox, LLC., a Birmingham, AL-based revenue cycle company specializing in autonomous medical coding powered by artificial intelligence raises $1.5M from TN3, LLC, an Arizona based Private Equity Capital firm.
- XpertDox's XpertCoding solution harnesses the power of artificial intelligence in order to autonomously code medical claims faster, more accurately, and cheaper than traditional manual processes. XpertDox is utilizing the funding to
Read More
Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures
What You Should Know:
- The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’s immersive virtual reality software.
- The results of the trial showed that the majority of patients (13/17) using the XRHealth VR technology did not need
Read More
Children’s Oncology Group Taps Tempus to Provide Genomic Sequencing for Pediatric Cancer Patients
What You Should Know:
-Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Epic Launches Life Sciences Program with Clinical Trial Matchmaking
What You Should Know:
- Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare.
- The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies.
Unifying Clinical Research with Care Delivery
Providers across the world use Epic to
Read More
RWJUH Opens Center for Innovation for Medical Research
What You Should Know:
- Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, and Rutgers Robert Wood Johnson Medical School (RWJMS) launched a new model for medical research and innovation today at the grand opening of its Center for Innovation, located on the main campus of the hospital.
- The Center for Innovation is a partnership between RWJUH and Rutgers RWJMS to bring together clinicians, researchers and private industry to invent and develop new
Read More
LifePoint Health and Google Cloud Announce Multi-Year Partnership
What You Should Know:
- LifePoint Health and Google Cloud announced a multi-year partnership aimed at using Google Cloud’s Healthcare Data Engine to transform healthcare delivery in communities across the U.S.
- The Healthcare Data Engine aggregates and organizes data from multiple sources, and for LifePoint, will be used by a patient’s healthcare provider to help clinicians gain further insight into patients records and data. This collaboration brings
Read More
Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
What You Should Know:
- Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
- The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
Castlight + Vera Appoints New CEO; Rebrands as Apree Health
What You Should Know:
- Vera Whole Health, Inc. and Castlight Health, Inc. appoints former Cerner President Donald Trigg as chief executive officer (CEO)
- In addition, the companies have rebranded as apree health that will be combine Castlight’s healthcare navigation platform with Vera’s advanced primary care solutions to improve patient outcomes and transform the healthcare industry.
Donald Trigg Background
Donald Trigg most recently served as president of
Read More
Power Launches with $7M to Diversify Clinical Trials
What You Should Know:
- Power, a patient-friendly platform designed to improve access to clinical trial studies emerges from stealth with $7M in seed funding.
- The round was led by Footwork and CRV, with additional investments from ARTIS Ventures, South Park Commons, and AirAngels to help Power bring the process of discovering and accessing clinical trials into the future.
Modernising and Simplifying Accessibility to Clinical Trials
Eighty-six percent
Read More